These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis. Hines LA, Trickey A, Leung J, Larney S, Peacock A, Degenhardt L, Colledge S, Hickman M, Grebely J, Cunningham EB, Stone J, Dumchev K, Griffiths P, Vickerman P, Mattick RP, Lynskey M. Lancet Glob Health; 2020 Jan; 8(1):e76-e91. PubMed ID: 31839143 [Abstract] [Full Text] [Related]
8. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P, Homelessness, HIV, and HCV Review Collaborative Group. Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656 [Abstract] [Full Text] [Related]
11. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators? Leung J, Peacock A, Colledge S, Grebely J, Cunningham EB, Hickman M, Vickerman P, Stone J, Trickey A, Dumchev K, Lynskey M, Hines L, Griffiths P, Mattick RP, Degenhardt L, Larney S. J Infect Dis; 2019 Jun 05; 220(1):78-90. PubMed ID: 30726973 [Abstract] [Full Text] [Related]
12. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique. Semá Baltazar C, Boothe M, Kellogg T, Ricardo P, Sathane I, Fazito E, Raymond HF, Temmerman M, Luchters S. BMC Public Health; 2020 Jun 03; 20(1):851. PubMed ID: 32493347 [Abstract] [Full Text] [Related]
13. Frequency of injecting among people who inject drugs: A systematic review and meta-analysis. Colledge S, Leung J, Larney S, Peacock A, Grebely J, Hickman M, Cunningham E, Trickey A, Stone J, Vickerman P, Degenhardt L. Int J Drug Policy; 2020 Feb 03; 76():102619. PubMed ID: 31864107 [Abstract] [Full Text] [Related]
14. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Lancet Infect Dis; 2018 Dec 03; 18(12):1397-1409. PubMed ID: 30385157 [Abstract] [Full Text] [Related]
15. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. PLoS Med; 2014 Jun 03; 11(6):e1001663. PubMed ID: 24937136 [Abstract] [Full Text] [Related]
16. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, Vickerman P, Blach S, Cunningham EB, Dumchev K, Lynskey M, Stone J, Trickey A, Razavi H, Mattick RP, Farrell M, Dore GJ, Degenhardt L. Addiction; 2019 Jan 03; 114(1):150-166. PubMed ID: 30035835 [Abstract] [Full Text] [Related]
17. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P, HIV and HCV Incidence Review Collaborative Group. Lancet Gastroenterol Hepatol; 2023 Jun 03; 8(6):533-552. PubMed ID: 36996853 [Abstract] [Full Text] [Related]
18. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique. Semá Baltazar C, Horth R, Boothe M, Sathane I, Young P, Chitsondzo Langa D, Condula M, Ricardo H, Dengo Baloi L, Cummings B, Schaad N, Gouveia L, Teodoro E, Raymond HF. BMC Infect Dis; 2019 Dec 02; 19(1):1022. PubMed ID: 31791273 [Abstract] [Full Text] [Related]
19. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis. Syangbo A, Hickman M, Colledge-Frisby S, Leung J, Grebely J, Larney S, Degenhardt L, Trickey A. Drug Alcohol Rev; 2023 Mar 02; 42(3):569-581. PubMed ID: 36600489 [Abstract] [Full Text] [Related]
20. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Horyniak D, Wagner KD, Armenta RF, Cuevas-Mota J, Hendrickson E, Garfein RS. Int J Drug Policy; 2017 Sep 02; 47():9-17. PubMed ID: 28683432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]